Pulmonx (LUNG) Cash from Investing Activities (2019 - 2025)

Pulmonx (LUNG) has 7 years of Cash from Investing Activities data on file, last reported at $8.7 million in Q3 2025.

• Cash from Investing Activities for Q3 2025 came in at $8.7 million, up 29.03% year-over-year; the trailing twelve-month figure through Sep 2025 was $44.6 million (up 6713.76% YoY), and the FY2024 annual result was $17.5 million, up 970.75% from the prior year.
• Cash from Investing Activities climbed to $8.7 million in Q3 2025 per LUNG's latest filing, from $5.5 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $16.3 million in Q1 2025 and troughed at -$29.1 million in Q4 2021.
• A 5-year average of -$237684.2 and a median of -$727000.0 in 2022 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2021 and 2023: Cash from Investing Activities tumbled 4392.11% in 2021, then soared 2143.18% in 2023.
• A 5-year view of Cash from Investing Activities shows it stood at -$29.1 million in 2021, then jumped by 97.5% to -$727000.0 in 2022, then plunged by 278.95% to -$2.8 million in 2023, then soared by 610.6% to $14.1 million in 2024, then sank by 38.07% to $8.7 million in 2025.
• Business Quant data shows LUNG's Cash from Investing Activities at $8.7 million in Q3 2025, $5.5 million in Q2 2025, and $16.3 million in Q1 2025.